Filing Details

Accession Number:
0001179110-15-012849
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-02 14:51:26
Reporting Period:
2015-08-31
Filing Date:
2015-09-02
Accepted Time:
2015-09-02 14:51:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1423824 Alder Biopharmaceuticals Inc ALDR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1033501 M Stephen Dow C/O Sevin Rosen Funds
13355 Noel Road, Suite 1350
Dallas TX 75240
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-08-31 16,218 $38.75 282,278 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. Represents 15,877 Common Shares sold directly by Sevin Rosen Fund IX L.P. and 341 Common Shares sold directly by Sevin Rosen IX Affiliates Fund L.P. pursuant to Rule 144 under the Securities Act of 1933, as amended.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at pricing ranging from $38.61 to $38.92 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. Total Common Shares of 282,278 represents 88 shares owned by SRB Associates IX L.P. and 282,190 shares owned directly by The Dow Family Trust ("Dow Trust"). Reporting person is a member of the general partner of SRBAIX and disclaims beneficial ownership except to the extent of his proportionate interest in these shares. Reporting person is a trustee of the Dow Trust.